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INVESTIGATION
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elegans: A Model for Marfan Syndrome
Pauline Fotopoulos,* Jeongho Kim,† Moonjung Hyun,* Waiss Qamari,* Inhwan Lee,* and Young-Jai You*,1
*Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia 23298 and
†Department of Biological Sciences, Inha University, Incheon, 402-751, South Korea
ORCID ID: 0000-0002-5716-5418 (Y.-J.Y.)
ABSTRACT mua-3 is a Caenorhabditis elegans homolog of the mammalian ﬁbrillin1, a monogenic cause of
Marfan syndrome. We identiﬁed a new mutation ofmua-3 that carries an in-frame deletion of 131 amino acids in
the extracellular domain, which allows the mutants to survive in a temperature-dependent manner; at the per-
missive temperature, the mutants grow normally without obvious phenotypes, but at the nonpermissive temper-
ature, more than 90% die during the L4 molt due to internal organ detachment. Using the temperature-sensitive
lethality, we performed unbiased genetic screens to isolate suppressors to ﬁnd genetic interactors of MUA-3.
From two independent screens, we isolated mutations in dpy-17 as a suppressor. RNAi of dpy-17 in mua-3
rescued the lethality, conﬁrming dpy-17 is a suppressor. dpy-17 encodes a collagen known to genetically interact
with dpy-31, a BMP-1/Tolloid-like metalloprotease required for TGFb activation in mammals. Human ﬁbrillin1
mutants fail to sequester TGFb2 leading to excess TGFb signaling, which in turn contributes to Marfan syndrome
or Marfan-related syndrome. Consistent with that, RNAi of dbl-1, a TGFb homolog, modestly rescued the lethality
of mua-3 mutants, suggesting a potentially conserved interaction between MUA-3 and a TGFb pathway in
C. elegans. Our work provides genetic evidence of the interaction between TGFb and a ﬁbrillin homolog, and
thus provides a simple yet powerful genetic model to study TGFb function in development of Marfan pathology.
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Marfan syndrome is an autosomal dominant connective tissue disorder
and is among the most frequent (3/10,000) monogenic diseases world-
wide (Ramirez and Dietz 2007; Gao et al. 2010). Patients exhibit con-
nective tissue and skeletal defects such as elongated extremities, joint
hypermobility, scoliosis, striae, and chest wall deformities (Ramirez
and Dietz 2007).
Marfan syndrome results from mutations in the fbn1 gene (Dietz
et al. 1991; Pyeritz 2000), which encodes an extracellular matrix (ECM)
glycoprotein, Fibrillin-1 (FBN1) (Corson et al. 1993). FBN1 is a major
component of the FBN1-rich microﬁbrils, a scaffold of elastic ﬁbers
(Kielty et al. 2005). Intact activity of FBN1 is critical to maintain the
aortic wall structure, which consists of elastic ﬁbers, collagen ﬁbrils, and
smooth muscle cells (SMCs). However, in Marfan patients, these struc-
tures are defective and altered due to reduced activity of FBN1 (Cui
et al. 2014). As a result, Marfan syndrome patients die mostly due to
aortic aneurysm, dissection, and rupture (Judge and Dietz 2005).
Among multiple functional domains, FBN1 contains nine TGFb
binding domains that are highly homologous to latent TGFb binding
proteins (Isogai et al. 2003; Hubmacher et al. 2006). Once secreted,
FBN1 monomers aggregate and form beaded structures, which form
macro-aggregates, microﬁbrils (Ramirez and Dietz 2007). Within these
microﬁbrils, FBN1 sequesters TGFb and BMPs in the ECM (Isogai
et al. 2003; Sengle et al. 2008; Ramirez and Rifkin 2009). In patients
with Marfan syndrome, defects in FBN1 lead to excess TGFb signaling,
which results in the pleiotropic manifestations of disease (Ramirez and
Dietz 2007).
TGFb is involved in cell proliferation, differentiation, apoptosis,
migration, immunity, angiogenesis, ECM production, and the devel-
opment of many organs (Massague 2000; Massague and Chen 2000;
Massague and Wotton 2000). TGFb activation occurs following the
release from the ECM, which is mediated by metalloproteases such as
BMP-1 (Ge and Greenspan 2006; ten Dijke and Arthur 2007). Active
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TGFb binds to its serine/threonine transmembrane receptors, which in
turn phosphorylate SMADs to regulate the transcription of genes
(Neptune et al. 2003).
The Caenorhabditis elegans genome contains two clear homologs of
human FBN1, fbn-1 and mua-3 (Culetto and Sattelle 2000; Bercher
et al. 2001; Frand et al. 2005). MUA-3 localizes to hypodermal cells,
to which body wall muscle adheres and which are required for adhesion
of the hypodermis to the cuticle (Pleneﬁsch et al. 2000; Bercher et al.
2001). A defect in mua-3 is characterized by progressive muscle
detachment throughout larval development (Bercher et al. 2001).
fbn-1 is required for proper molting, speciﬁcally during the L3/L4 molt
and L4/young adult molt (Frand et al. 2005). Complete knockout of
mua-3 is lethal, whereas fbn-1 knockdown mutants exhibit molting
defects, sterility, larval lethality, and slow growth, and lay dead eggs
(Bercher et al. 2001; Frand et al. 2005). Mutations in fbn-1 and mua-3
genes cause molting defects that can be attributed to defects in a tissue
that is functionally equivalent to connective tissue in mammals (Bercher
et al. 2001; Frand et al. 2005). This demonstrates that C. elegans ﬁbrillin
genes have a conserved role in maintaining connective tissue-like tissue
integrity, as does human FBN1. The molting defects of these C. elegans
mutants suggest that the mechanical strain of molting (shedding and
rebuilding the exoskeleton) mimics Marfan syndrome pathology where
weak connective tissue is torn.
Interestingly, in C. elegans most genes that regulate body size are
components of a TGFb pathway (Patterson and Padgett 2000). Be-
cause alteration in body size is a prominent indicator of Marfan syn-
drome, it suggests that connective tissue-like tissue integrity mediated
by mua-3 or fbn-1 could be related to TGFb signaling pathways in
C. elegans because they are implicated in Marfan syndrome.
In this study, we identiﬁed a new allele of mua-3 that causes death
speciﬁcally during the L4 molt in a temperature-dependent manner.
Using this phenotype, we performed unbiased genetic screens
and found DPY-17 as a genetic interactor of MUA-3. We also found
a potential interaction between MUA-3 and a TGFb ligand DBL-1,
suggesting a potential conservation in interaction between a ﬁbrillin
homolog and a TGFb pathway. Our study could be used to further
establish a worm model of Marfan syndrome.
MATERIALS AND METHODS
C. elegans strains and culture conditions
C. elegans were routinely grown on NGMSR plates (Avery 1993). All
animals were maintained at 20 on E. coli HB101 (Sulston and Hodgkin
1988) except formua-3(uy19) (YJ35) mutants, which were maintained at
15. The wild-type strain was C. elegans variant Bristol, strain N2. Mu-
tant strains used are YJ35 mua-3(uy19) III, OT136 mua-3(rh195) III,
CB164 dpy-17(e164) III, CB1072 unc-29(e1072) I, DP38 unc-119(ed3) III,
CB1282 dpy-20(e1282ts) IV, CB369 unc-51(e369) V, RB1547 sta-2(ok1860)
V, NU3 dbl-1(nk3) V, and YJ208 mua-3(uy19) III; dbl-1(nk3) V.
Mapping of the new mua-3 mutation
SNP mapping: The death phenotype during the L4 molt was called
drop-dead, Drd. To identify the chromosome on which the drd muta-
tion resides, the mutant was crossed to four mutants: unc-29 I, unc-119
III, dpy-20 IV, and unc-51 V. F2s homozygous for the marker from each
cross produced approximately 20% Drd except the cross to unc-119
(,3%). This mapped drd to chromosome III. Mating unc-119(ed3) with
Drd homozygotes yielded wild-type F1 progeny, indicating the muta-
tion is recessive. Thirteen out of 14 F2 Unc produced no Drd progeny
(F3), validating that drd is linked to unc-119 on chromosome III. One
Unc produced progeny with both Unc and Drd phenotypes by recom-
bination. This unc-119(ed3) drd (uy19) grows normally at 15. We used
it for further SNP mapping. The unc-119(ed3) drd (uy19) double
mutants mated with Hawaiian CB4856 males produced wild-type prog-
eny (F1). We placed 48 F2 Unc singly onto plates, and then the DNA
of F3 progeny was collected for further SNP mapping (Wicks et al.
2001; Davis et al. 2005). Because unc-119 is located at 10.9 Mb, SNP
markers on ZK1236 (8.4 Mb), C07A9 (9.6 Mb), T21C12 (10.5 Mb),
Y39A1A (10.6 Mb), and Y75B8A (12.0 Mb) were selected. One hun-
dred percent (44/44) of Unc progeny carried only the N2 marker (0%
Hawaiian) at 12.0 Mb, suggesting that the mutation is located to the left
of unc-119. Forty-eight percent (21/44) of Unc progeny carried only the
N2 marker at T21C12 (10.5 Mb) and 58% (26/45) of Unc progeny
carried only the N2 marker at Y39A1A (10.6 Mb). Based on the re-
combination frequencies, we estimated the drd location at approxi-
mately 10.1–10.2 Mb.
Whole genome sequencing: The genomes of the mutant strains after
outcrossing twice against N2 were sequenced using Illumina sequenc-
ing. Sequences were aligned to the WS220 reference C. elegans genome
with bowtie2 (Langmead and Salzberg 2012), variants called with the
samtools/bcftools suite (Li et al. 2009), and effects on gene function
predicted and variants ﬁltered with snpEff and SnpSift (Cingolani et al.
2012). Further speciﬁc analyses used vcftools (Danecek et al. 2011),
bedtools (Quinlan and Hall 2010), and custom scripts.
After whole genome sequencing, we found a single deletion in the
mua-3 gene, but no other mutations in the range of 9.8 Mb to 10.5 Mb
for chromosome III. The mutation was also validated because the
original strain was from the knockout consortium of C. elegans, where
the mutations are generated by the UV/TMP method to create dele-
tions. The new allele of mua-3(uy19) contains a 488-bp in-frame de-
letion that includes parts of the 30th and 31st exons and the short intron
between them. The ﬂanking sequences are as follows: 59 end of the
deletion: 59-TGAGGAGAATGGATA-39 and 39 end of the deletion:
59-CACCACAGTCCAGTC-39. The deletion results in deletion of the
following 131 amino acids:
RCRCRNGYHDDDPAHPGHRC SFMINECDSS NLNDCDRNAN
CIDTAGGYDC ACKAPYRDEG PPQSPGRICR LNECLNPNRN
TCDRNADCRD LDYGYTCTCR HGFYDQSPNP QEPGRICIEF
QQEEHIERVK V.
Characterization of mua-3 phenotypes
Temperature-dependent lethality: Eggs were isolated via hypochlo-
rite treatment (Sulston and Hodgkin 1988) and then harvested in M9
buffer to obtain a synchronous population. Synchronized populations
of YJ35 mua-3(uy19) mutants and wild-type were transferred to E. coli
HB101 seeded NGM plates at the L1 stage and cultivated at 15, 20, or
25 in triplicate. Synchronized populations of approximately 100mua-3
and wild-type L1s were placed onto each plate. At 25, approximately
30 hr after L1s were given food, L4s started to molt. At 20, L4s started
to molt after approximately 40 hr, and at 15 L4s started to molt after
approximately 60 hr. The majority of death occurred during the molt;
therefore, timeframes for the experiments were designated accordingly.
The number of dead animals and the number of total animals were
counted to determine percent survival of mua-3 and wild-type at each
hour from 50 hr at 15, 37 hr at 20, and 30 hr at 25.
Sterility: To determine the number of offspring produced by
individual animals of OT136 mua-3(rh195) mutants and wild-type,
ﬁve L4s of each strain were transferred singly to E. coli-seeded NGM
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plates and their progeny were counted. Each worm was transferred to
a new plate every day to avoid crowding and to visualize all the
progeny easily. Progeny were counted 3 d later.
Suppressor screens
Primary screen: mua-3(uy19) were collected at the L4 stage and were
randomly mutagenized with ethyl methanesulfonate (EMS) (Brenner
1974). Po animals were plated onto E. coli HB101 seeded plates and
moved to 15. F1 progeny were synchronized and remained at 15.
The homozygous F2 generation was synchronized and moved to 25.
The surviving animals were isolated.
Secondary screen: Individual suppressors of the mua-3 mutant lethal-
ity were isolated and moved to individual plates at the restrictive tem-
perature, 25. Sterile animals and escapers (animals that produced more
than 90% of nonviable progeny) were removed. A total of 20 F2s passed
the secondary screen and were used to found lines maintained at 25.
Complementation test for Dpy suppressors: Unidentiﬁed suppressor
hermaphrodites were crossed with wild-type males. The F1 progeny
males were crossed with an alternate unidentiﬁed suppressor. The F1
progeny of this cross were counted to calculate the percentage of Dpy.
The percentage of males in the population was also counted to de-
termine whether Dpy progeny were from cross-fertilization or self-
fertilization. If 50% of the progeny were Dpy, then suppressors failed
to complement each other.
RNAi of dbl-1 and dpy-17
The bacteria-mediated feeding RNAi was performed as described
(Fraser et al. 2000), with the following modiﬁcations. The mua-3
(uy19) mutants were fed with the clones of dbl-1 and dpy-17 from
the Ahringer feeding library (Fraser et al. 2000; Kamath and Ahringer
2003). The plates containing NGM agar with 1 mM IPTG and 50 mg/ml
carbenicillin were inoculated with bacterial cultures grown 16–18 hr for
each targeted gene. L4-stage C. elegans were transferred to the plates
for each gene at 15. Forty-eight hours later, adults were removed and
the plates were placed at 25. Forty-eight hours later, the number of
progeny that survived was counted and the percentage was calculated.
The RNAi clones of dpy-17 and dbl-1 were sequenced and validated
(data not shown).
Photography
mua-3 mutants were observed under differential interference contrast
(DIC) microscopy using a Zeiss Axio A2 Imager at either 63· or 100·
magniﬁcations. Images were acquired using Zeiss Axiovision software.
Statistical analysis
Student’s t tests and one-way ANOVA test were performed to de-
termine statistical signiﬁcance.
mua-3 homology comparison
The phylogenetic tree was created using the MEGA program.
CLUSTALW was used for multiple sequence alignment. The p-distance
method was used to calculate distance and the neighbor-joining method
was used to create a tree. The tree was statistically evaluated by using
the bootstrap method (1000 times), and robustness of the tree branch
was indicated at the branch. The following protein sequences were used
for the phylogenetic analysis: C. elegans MUA-3 (NP_001022674.1),
C. elegans MUP-4 (NP_498645.1), C. elegans FBN-1 (NP_001263711.1),
Drosophila melanogaster DP (Dumpy; NP001260037.1), Homo sapiens
FBN1 (NP_000129.3), FBN2 (NP_001990.2), FBN3 (NP_115823.3), and
EYS (Eyes shut; NP_001278938.1). H. sapiens EYS sequence was included
as an outgroup member to infer the root of this unrooted tree.
RESULTS
Characterization of a mua-3(uy19) mutation
We acquired RB1547 from the Caenorhabditis Genetics Center (CGC),
which contains a deletion in sta-2. We observed a high rate of lethality
during the L4 molt at 25 (Figure 1A). After outcrossing against N2 two
times, we found the lethality was not linked to the deletion in sta-2.
After a series of SNP mappings, we located the lethal mutation on
chromosome III close to unc-119. Subsequent whole genome sequenc-
ing revealed a 488-bp (131 amino acids) in-frame deletion in themuscle
attachment abnormal-3, mua-3 gene (see Materials and Methods)
(Figure 1, B and C).
The mutants showed a lethal phenotype similar to the previously
reported mua-3 mutants, conﬁrming that the lethality is due to a mu-
tation in mua-3 (Bercher et al. 2001). From transmission electron
microscopy (TEM) observations of detachment zones of their mua-3
mutants, Bercher and others suggested that MUA-3 acts at the apical
hypodermal surface to maintain the attachment of the hypodermis to
the basal cuticle and that the primary defect in mua-3 mutants is the
failure of these attachments. But unlike the old allele mua-3(ar62) that
die during various stages as early as at L1 (Bucher and Greenwald
1991), the new mutants grow normally until the L4 molt without
any visible defects in development, and within 2–3 hr of molting, most
die (Figure 1D) (30 hr to 33 hr from L1s is when most of the death
occurs). At the L1, L2, and L3 stages, mutants rarely died. The occa-
sional escapers after the L4 molt looked pale and sick immediately after
molting, but within 2 hr they appeared normal and reproduced nor-
mally (data not shown).
When we examined the cause of sudden death during L4 molt, we
found that internal organs such as the pharynx and gonad were detached
and misplaced (Figure 2, A, D, and E). The gonad develops normally
before molting at nonpermissive temperatures (Figure 2, B and C). This
shows that MUA-3 is required for the organ attachment, consistent with
the previous ﬁnding by Bercher et al. 2001. The sudden death during the
L4 molt could suggest that mechanical strain during the L4 molt is
sufﬁciently stressful to cause all the tearing in our mutants.
The sequence of MUA-3 shares high homology with that of the
human FBN1, mutations in which are the cause of Marfan syndrome
(Figure 1E). Our results may suggest that the detachment of internal
organs during the L4 molt could mimic certain aspects of Marfan
pathology such as aneurysm or aortic dissection in the heart caused
by weak connective tissue integrity under mechanical stress.
dbl-1, a homolog of TGFb2, genetically interacts
with mua-3
Because the sequence of mua-3 is most similar to the human ﬁbrillin1
gene, and because the phenotype of our new mutant mimics certain
aspects of Marfan pathology, we investigated the potential genetic in-
teraction betweenmua-3 and TGFb2 signaling. Recent studies show that
overactivation of the TGFb2 pathway results in Marfan pathology and
appearances such as connective tissue defects and long stature (for review
see Lindsay and Dietz 2011). Interestingly, overexpressing DBL-1, a ho-
molog of TGFb2, increases body size in C. elegans (Morita et al. 2002).
We hypothesized that the DBL-1 TGFb pathway regulates body size in
C. elegans as TGFb2 does in humans, and thus in the mua-3 mutants
increased TGFb signaling may contribute to lethality. To test this
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hypothesis, we knocked down the expression of dbl-1 by RNAi and
examined whether mua-3 lethality was reduced. RNAi reduced the le-
thality ofmua-3mildly yet signiﬁcantly, suggesting a potential conserved
link between excess TGFb signaling and misregulation in body size
shown in Marfan syndrome in C. elegans (Figure 3A). We generated
double mutants of mua-3; dbl-1 to further examine the interaction be-
tween two genes. The existing allele of dbl-1(nk3) carries a deletion
covering the entire gene, and thus no protein is made. The double
mutants did not survive any better than mua-3 single mutants at 25
(Figure 3B). Interestingly, however, the double mutants die more at 15,
clearly showing a genetic interaction between two genes (Figure 3C).
That the null mutation of dbl-1 cannot rescue mua-3 but RNAi knock-
down of dbl-1 can suggest that complete knockout of dbl-1 does not help
mua-3, but reduction of MUA-3 levels does. Also, the increase of the
death in the double mutants shows there is genetic interaction between
these two. This is fully consistent with the ﬁndings in mammals. Re-
duction of TGFb2 by various means alleviates Marfan syndrome. How-
ever, conditional yet complete knockout TGFb2 receptor in smooth
Figure 2 The phenotypes of mua-3. (A) Representative
DIC microscopy image of mua-3(uy19) mutants dying
during L4 molt. White arrow shows a normal-looking
gonad arm with germ cell nuclei. The red arrow shows
misplaced and detached gonad. Scale bar = 30 mm. A,
anterior; P, posterior; D, dorsal; and V, ventral. (B and C)
The gonad structures of mua-3(uy19) at early L4 stage
before molt show normal development of gonads at
25. Scale bar = 10 mm. (D and E) The tips of the phar-
ynxes of two dying mua-3(uy19) were detached from
the tips of the mouths. Scale bar = 20 mm
Figure 1 Characterization of
a newly isolated mua-3 allele,
uy19. (A) Temperature-dependent
lethality of the newly isolated
mua-3 mutant. The numbers of
dead animals and total animals
were counted to calculate percent
survival. Animals were synchro-
nized and plated as L1s and the
percentage of survival was mea-
sured after they passed the L4
molt; 61 hr for 15, 40 hr for 20,
and 30 hr for 25. The numbers
are average percent survival 6
SEM. (B) A schematic drawing of
the exons and introns of mua-3
gene and the location of the de-
letion. (C) A schematic drawing of
the domain structure of themua-3
gene (Bercher et al. 2001) and the
location of the deletion. (D) Time
course of death of the mua-3
(uy19) mutants at 25. Very few
deaths were observed until 30 hr
from L1. Then, within 3–4 hr, more than 90%were dead. The time window of death was somewhat wider than a worm’s molting period (approximately 2 hr)
because the mutants are not perfectly synchronized, and thus the time to reach the molt varies among the animals. The numbers are average percent
survival6 SEM. (E) A phylogenetic tree to show MUA-3 is a homolog of human ﬁbrillins. Compared ﬁbrillin homologs are C. elegansMUA-3, C. elegans
MUP-4, C. elegans FBN-1, Drosophila melanogaster DP, Homo sapiens FBN1, FBN2, and FBN3. H. sapiens EYS sequence was included as an outgroup
member to infer the root of this unrooted tree.
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muscle cells impairs the contractile apparatus of vascular smooth muscle
and exacerbates the aortic disease induced by mutation of ﬁbrillin1 (Li
et al. 2014).
Two independent alleles of mua-3 show
temperature-dependent phenotypes
The lethality of mua-3(uy19) mutants was reduced when the mutants
were grown at two lower temperatures, 15 and 20 (Figure 4, A and B).
To examine whether the temperature sensitivity is speciﬁc to this mu-
tation or could be seen in other mua-3 mutations, we tested mua-3
(rh195)mutants, the only viablemua-3mutant isolated by Bercher et al.
(2001). Wild-type animals have fewer progeny at 25 than 20. How-
ever, they do not show any sterility phenotype. On the contrary, mua-3
(rh195) grew normally at 20 with reduced brood size but became
completely sterile when grown at 25 due to gonadal detachment (see
Figure 4, C–E for quantiﬁcation of their sterility). This is a milder
phenotype than that of mua-3(uy19), which dies at the L4 molt, yet
both mutations show severe phenotypes at a high temperature.
Increased temperature manifests the reduction of body
length in the dbl-1 null mutant
We noticed that the phenotype of mua-3 is dependent on tempera-
ture, and so is that of the null mutant of dbl-1, the C. elegans TGFb2
homolog. At 25 the mutants are shortest, at 15 the mutants are
longest, and at 20 the body length is in between the two temperatures
(25 and 15) (see Figure 5, A and B for quantiﬁcation). This allele
does not produce any protein, yet the body length is more reduced at
a high temperature. This result suggests that temperature inﬂuences
the body size phenotype regardless of the stability or function of the
protein. Moreover, similar to the case ofmua-3, increased temperature
exacerbates the phenotype.
Mutations in dpy-17 suppress mua-3(uy19) lethality
To identify genes that interact with mua-3(uy19), we performed two
independent unbiased genetic screens using ethyl methyl sulfonate
(EMS) mutagenesis to identify suppressors. We used the tempera-
ture-dependent lethality of mua-3(uy19) to sort the resulting mutants
of the genetic screens.
Among 20 isolates, seven suppressors were picked for further study
after we removed weak suppressors, sterile mutants, and escapers
(animals that produced nonviable progeny at nonpermissive temper-
atures) (Table 1). We conﬁrmed their rescue by measuring survival at
25 (Figure 6A). Because the screens were performed with F2 progeny
Figure 3 dbl-1 genetically interacts with mua-3 mutants. (A) RNAi of
TGFb2 homolog (dbl-1) rescued the mua-3 lethality at 25. The num-
bers are average percent survival 6 SEM. (B) A mutation in dbl-1 did
not rescue the mua-3 lethality at 25. (C) A mutation in dbl-1 reduces
the survival of mua-3 at 15.
Figure 4 mua-3 mutants showed
temperature-dependent pheno-
types. (A) mua-3(uy19) mutants
do not show lethality at 15. (B)
Increase of temperature to 20
reduces survival of mua-3(uy19)
mutants. (C and D) Another al-
lele of mua-3 mutants shows
temperature-dependent sterility.
mua-3(rh195)mutants show a nor-
mal gonad morphology at 20
(A, white arrow) but become ster-
ile due to detachment of the go-
nad at 25 (D, red arrows). (E) The
sterility induced by high tempera-
ture was quantiﬁed by counting
the progeny of mua-3 mutants
and wild-type animals grown at
20 and 25. P, 0.001 for com-
parison between the numbers of
progeny of mua-3 at 20 and 25
by Student’s t test.
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from mixed F1s, it is possible that some suppressors share the same
mother and contain mutations on the same alleles; yet, several sup-
pressors have distinct phenotypes. For example, S4, one of the strong
suppressors (Figure 6A), does not show a Dpy phenotype but shows
Eat (pale body color) and Unc (uncoordinated movement). Interest-
ingly, several suppressors of mua-3(uy19) from two independent
screens are smaller (Sma) or shorter (Dpy) in body length compared
to wild-type. Because one of the major pathways that determines body
size in C. elegans is a TGFb pathway, our results suggest the intriguing
possibility that MUA-3 may be involved in TGFb regulation in
C. elegans as in Marfan syndrome pathology in humans.
Four suppressors (S11, S18, S19, S23) looked very similar to each
other and shorter in body length than wild-type, exhibiting the Dpy
phenotype. They failed to complement dpy-17(e164), indicating that
they all carry mutations in dpy-17. We isolated dpy-17mutations from
two independently performed screens (S11 is from the ﬁrst screen;
S18, S19, and S23 are from the second screen), strongly suggesting that
dpy-17 mutations suppress mua-3 lethality. S11 is close to sterile,
probably due to other mutations; we excluded it from further study.
To conﬁrm dpy-17 suppression of mua-3 lethality, we treated mua-3
mutants with dpy-17 RNAi. dpy-17 RNAi rescued mua-3 lethality
(Figure 6B), validating dpy-17 as a suppressor. The maximum rescue
rate we saw was approximately 50% survival. Only approximately 50%
of wild-type animals treated with dpy-17 RNAi showed a clear Dpy
phenotype (data not shown), suggesting the low rescue percentage
could be due to incomplete RNAi effect.
dpy-17 encodes a cuticle collagen required for normal body mor-
phology (Novelli et al. 2006). Genetic studies show that a gain-of-
function mutation of dpy-17 suppresses phenotypes of dpy-31
mutations, indicating a genetic interaction between the two. dpy-31
encodes a homolog of the human bone morphogenic protein-1 (Novelli
et al. 2004). The human bone morphogenic protein-1 is a tolloid-like
gene whose proteolytic activity is required for TGFb activation (Ge and
Greenspan 2006). Our screen results suggest a potential link between
MUA-3-associated and TGFb-associated molecules such as DPY-31 via
DPY-17 (Figure 6C).
DISCUSSION
In this study, we isolated a new mua-3 mutation that shows defects in
connective tissue-like tissues that lead to death speciﬁcally during the
L4 molt in a temperature-sensitive manner. The sequence homology
and the similar phenotypes we and others found in mua-3 mutants
suggest that MUA-3 is a homolog of FBN1 and that the role of ﬁbrillin
genes in C. elegans and humans could be conserved. mua-3(uy19)
lethality that is speciﬁc during the L4 molt (but not in other molts)
could suggest that the mechanical strain may be most stressful during
the L4 molt.
The temperature dependence shown in two independent alleles of
mua-3 is interesting. Despite the wide use of temperature-sensitive (ts)
mutations, especially for studying essential genes that cause lethality
when they are deleted, the molecular basis of ts phenotypes is largely
unknown. It is generally assumed that the lethality results from ther-
mal inactivation of gene products. However, there are also several lines
of evidence suggesting that the exacerbated phenotypes at the non-
permissive temperature come from the changes in conditions under
which the molecules function that coincide with the temperature shift
(Van Voorhies and Ward 1999; Masuda et al. 2013), such as rates of
metabolism or development processes. Our result that a null mutation
of dbl-1 has different body size depending on temperature also sup-
ports this idea. Therefore, higher temperature may exacerbate mua-3
phenotypes by increasing metabolic rate and/or by speeding the
Figure 5 dbl-1 null mutants showed temperature-de-
pendent phenotypes. (A) The 2-day-old dbl-1(nu3)
mutants grown at different temperatures show different
body lengths; they are longest at 15 and shortest at
25. (B) Quantiﬁcation of the difference in body lengths.
More than 20 mutants were used for each sample and
the experiments were repeated three times. P , 0.001
by one-way ANOVA.
n Table 1 Characterization of appearance of isolated suppressors
of the mua-3(uy19) lethality
Suppressors Phenotypes
S1 Small body size, pale body color, uncoordinated
movement (Unc)
S3 Pale body color, small body size (Sma)
S4 Pale body color, uncoordinated movement (Unc)
S5 Uncoordinated movement (Unc)
S6 Small body size, pale body color
S7 Small body size, pale body color, uncoordinated
movement (Unc)
S9 Short body length (Dpy), similar to dpy-17
mutants
S10 Small body size
S11 Short body length (Dpy), similar to dpy-17
mutants
S16 Slow growth, slow movement, small body size
(Sma), pale body color
S18 Short body length (Dpy), similar to dpy-17
mutants
S19 Short body length (Dpy), similar to dpy-17
mutants
S20 Thin body width
S21 Long body length (Lon)
S22 Slow growth, slow movement, small body size
(Sma), pale body color
S23 Short body length (Dpy), similar to dpy-17
mutants
S24 Small body size (Sma)
S25 No obvious phenotype
S26 Dark body color
S27 Dark body color
S1–S11 are suppressors isolated from the ﬁrst screen. S16–S27 are suppressors
isolated from the second screen. The suppressors tested in Figure 3A are in
bold.
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developmental processes. One of the current treatments for Marfan
syndrome is b-adrenergic blockers that lower heart rate and slow aortic
growth. However, this only ameliorates the deleterious symptoms of
progressive aortic root enlargement and aortic dissection. If metabolic
rate plays any role in regulating disease progression, then a combined
treatment with b-adrenergic blockers and a drug that decreases met-
abolic rate may help further to alleviate Marfan syndrome.
We identiﬁed dpy-17 mutations as suppressors of mua-3 from two
independent genetic screens, suggesting that DPY-17 and MUA-3 ge-
netically interact. DPY-17 encodes a cuticle collagen. C. elegans genome
contains approximately 154 collagen genes, many of which are essential
and developmental stage-speciﬁc (Johnstone 1994, 2000; Kramer
1997). In Marfan syndrome models, the tunica media of the aorta,
which normally contains elastin sheets and collagen, is fragmented,
disorganized, and lost (Cui et al. 2014). Also, it has been reported that
collagen metabolism is abnormal in Marfan patients and overexpres-
sion of a collagen gene results in reduction of ﬂexibility of extracellular
matrix (ECM), thus contributing to Marfan pathology (Priest et al.
1973; Tajima 1995; Robinson et al. 2006). This might suggest that
excessive collagen could negatively affect the structure of ECM when
there is not enough Fibrillin-1, and that removal of DPY-17 when
mua-3 function is reduced might prevent the formation of abnormal
ECM and rescue the lethality during the L4 molt.
DPY-17 is known to interact with DPY-31 (Novelli et al. 2006).
DPY-31 is a homolog of bone morphogenic protein-1 metallopro-
tease. The human bone morphogenic protein-1 is a tolloid-like gene
whose proteolytic activity is required for TGFb activation (Ge and
Greenspan 2006). In humans, increased activity of other metallopro-
teases such as MMP2 (metalloprotease 2) and MMP9 has clear impli-
cations in Marfan pathology; in Marfan syndrome, these endopeptidases
cleave ECM components, including microﬁbrils, elastic ﬁbers, and col-
lagen, resulting in loss of ECM integrity and aggravation of the syn-
drome (Chung et al. 2007, 2008). Our study suggests that DPY-31 in C.
elegans and BMP-1 in humans may be involved in TGFb dysregulation,
a process that has been implicated in Marfan syndrome disease pro-
gression (Ge and Greenspan 2006).
Together, our results suggest that Fibrillin-1, TGFb, and a Tolloid-
like protein may act in concert to modulate TGFb availability and
connective tissue-like tissue integrity in C. elegans. These results fur-
ther suggest the molecular conservation among known genetic causes
for Marfan or Marfan-related syndromes between humans and
C. elegans, providing a useful genetic model for Marfan syndrome.
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